Nebula Research & Development LLC Acquires Shares of 19,363 Henry Schein, Inc. (NASDAQ:HSIC)

Nebula Research & Development LLC purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 19,363 shares of the company’s stock, valued at approximately $1,340,000.

Other hedge funds also recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC increased its stake in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC increased its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Finally, City State Bank purchased a new stake in shares of Henry Schein during the fourth quarter valued at $55,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Down 1.6 %

HSIC opened at $65.17 on Friday. The business’s 50 day moving average price is $69.21 and its 200 day moving average price is $71.78. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $7.98 billion, a PE ratio of 26.82, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company earned $0.66 EPS. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on HSIC. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Finally, StockNews.com lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $81.10.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.